Clinical Trial

A Clinical Study Exploring CT1194C in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated July 16, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
A Clinical Study to Investigate the Safety, Efficacy, and Cellular Metabolism of CT1194C CAR-T Cell therapy, in Patients with Relapsed/Refractory B-Cell NonHodgkin Lymphoma.
Trial Details
NCT Number NCT07068906
Lead Sponsor Institute of Hematology & Blood Diseases Hospital, China
Conditions B-Cell Non-Hodgkin Lymphoma
Enrollment 27 participants
Start Date 2025-07-15
Primary Completion 2026-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-16